Literature DB >> 3498605

Monocyte-macrophage (M-M) functions in asymptomatic hemophiliacs and supertransfused thalassemics.

M S Sternbach1, C Tsoukas, M Paquin, N Lajeunesse, H Strawczynski.   

Abstract

Patients suffering from acquired immune deficiency syndrome (AIDS) succumb to opportunistic infections due to a generalized failure of their cell-mediated immune defenses. The monocyte-macrophage (M-M) system plays an important role in host defense against viruses, protozoa, mycobacteria, and tumours, all potentially involved in the terminal stages of AIDS. We studied M-M functions in 55 asymptomatic hemophiliacs, 20 supertransfused thalassemics, and 9 von Willebrand's syndrome patients over a period of 17 months to establish the part played by chronic repeated blood component transfusions on the macrophage defense system. We found a significant impairment of chemotaxis in 24 out of 55 hemophiliacs, 13 out of 20 thalassemics, and 4 out of 9 von Willebrand's patients. In contrast, Candida pseudotropicalis killing was markedly increased in all 3 patient groups, while Candida phagocytosis was most significantly diminished in thalassemics. Fc-receptor-dependent erythrophagocytosis showed wide variations in all patients, with a significant decrease only in thalassemics. Phorbol ester-activated nitroblue tetrazolium (NBT) reduction to formazan was normal in most cases, but background spontaneous NBT was often much higher than in the controls. Monocyte adhesion to plastic appeared impaired in hemophiliacs and von Willebrand's Syndrome patients, yet was of no statistical significance. It thus appears that continuous, repeated blood component transfusions cause an alteration of M-M functions. This may be either due to chronic, recurrent antigenic stimulation by foreign proteins transfused, or oncogenic and known immune suppressive viruses, like cytomegalovirus, Epstein-Barr virus, hepatitis, and human T cell lymphotropic virus III. This in turn may increase susceptibility to AIDS.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3498605

Source DB:  PubMed          Journal:  Clin Invest Med        ISSN: 0147-958X            Impact factor:   0.825


  4 in total

1.  Phenotypical and functional abnormalities of circulating neutrophils in patients with β-thalassemia.

Authors:  Brigitta Buttari; Elisabetta Profumo; Patrizia Caprari; Sara Massimi; Francesco Sorrentino; Laura Maffei; Marco Gabbianelli; Rachele Riganò
Journal:  Ann Hematol       Date:  2020-08-15       Impact factor: 3.673

2.  Infections in thalassemia and hemoglobinopathies: focus on therapy-related complications.

Authors:  Bianca Maria Ricerca; Arturo Di Girolamo; Deborah Rund
Journal:  Mediterr J Hematol Infect Dis       Date:  2009-12-28       Impact factor: 2.576

3.  Immune responses in beta-thalassaemia: heme oxygenase 1 reduces cytokine production and bactericidal activity of human leucocytes.

Authors:  Arnone Nithichanon; Inthira Tussakhon; Waraporn Samer; Chidchamai Kewcharoenwong; Manabu Ato; Gregory J Bancroft; Ganjana Lertmemongkolchai
Journal:  Sci Rep       Date:  2020-06-24       Impact factor: 4.379

4.  Premature aging of the immune system affects the response to SARS-CoV-2 mRNA vaccine in β-thalassemia: role of an additional dose.

Authors:  Rita Carsetti; Chiara Agrati; Valeria Maria Pinto; Barbara Gianesin; Rita Gamberini; Monica Fortini; Susanna Barella; Rita Denotti; Silverio Perrotta; Maddalena Casale; Aurelio Maggio; Lorella Pitrolo; Eleonora Tartaglia; Eva Piano Mortari; Francesca Colavita; Vincenzo Puro; Massimo Francalancia; Valeria Marini; Marco Caminati; Filippo Mazzi; Lucia De Franceschi; Gian Luca Forni; Franco Locatelli
Journal:  Blood       Date:  2022-10-13       Impact factor: 25.476

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.